A61K 2039/5152
Tumor cells
Official title: {Tumor cells}
A61K2039/5152 (Tumor cells) appears on 301 US grants and 558 published applications in this corpus.
Search patents in A61K- Granted patents
- 301
- Published applications
- 558
- Assignees
- 262
- Inventors
- 897
- Latest grant
- 14 Jul 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1979 | 1 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 2 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 1 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 2 | 0 |
| 1998 | 2 | 0 |
| 1999 | 7 | 0 |
| 2000 | 11 | 0 |
| 2001 | 11 | 4 |
| 2002 | 9 | 16 |
| 2003 | 7 | 31 |
| 2004 | 6 | 32 |
| 2005 | 3 | 28 |
| 2006 | 9 | 16 |
| 2007 | 7 | 17 |
| 2008 | 4 | 18 |
| 2009 | 9 | 26 |
| 2010 | 15 | 31 |
| 2011 | 9 | 32 |
| 2012 | 12 | 13 |
| 2013 | 10 | 20 |
| 2014 | 11 | 14 |
| 2015 | 7 | 16 |
| 2016 | 22 | 22 |
| 2017 | 22 | 32 |
| 2018 | 11 | 20 |
| 2019 | 16 | 24 |
| 2020 | 13 | 21 |
| 2021 | 17 | 35 |
| 2022 | 12 | 28 |
| 2023 | 9 | 15 |
| 2024 | 6 | 21 |
| 2025 | 12 | 15 |
| 2026 | 6 | 11 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Compositions and methods for multiplexed tumor vaccination with endogenous gene activation14 Jul 2026US 12,678,493 B2Yale University
- Vaccine compositions and methods for restoring NKG2D pathway function against cancers9 Jun 2026US RE50,908 E1Dana-Farber Cancer Institute, Inc.
- Targeting delivery system loaded with whole-cell components and use thereof28 Apr 2026US 12,611,448 B2Suzhou Ersheng Biopharmaceutical Co., Ltd
- C3d cellular and acellular vaccines for the prevention and treatment of cancer10 Feb 2026US 12,545,712 B2The Regents of the University of Michigan
- Compositions and methods related to tumor cell killers and vaccines20 Jan 2026US 12,527,821 B2The Brigham and Women S Hospital, Inc.
- Methods and materials for treating cancer3 Sep 2026US 2026/0256897 A1Mayo Foundation for Medical Education and Research
- A Vaccine Composition of Cells Expressing a Lentiviral Vector and Methods of Using27 Aug 2026US 2026/0250717 A1Meridian Therapeutics, Inc.
- Tumor cell vaccines20 Aug 2026US 2026/0240969 A1Neuvogen, Inc.
- Fusion cytokine compositions and methods of use thereof13 Aug 2026US 2026/0232779 A1Wisconsin Alumni Research Foundation
- Extracellular vesicles targeting dendritic cells and uses thereof30 Jul 2026US 2026/0216367 A1Lonza Sales AG
Most cited
By later US patents
- Non-linear amplitude dielectrophoresis waveform for cell fusion117US 6,916,656 B2Cyto Pulse Sciences, Inc. · 2005
- Compositions and methods using complexes of heat shock proteins and antigenic molecules for the treatment and prevention of neoplastic diseases108US 5,837,251 AFordham University · 1998
- Binding domain-immunoglobulin fusion proteins96US 7,754,208 B2Trubion Pharmaceuticals, Inc. · 2010
- Membrane-bound cytokine compositions comprising GM=CSF and methods of modulating an immune response using same90US 5,891,432 AThe Immune Response Corporation · 1999
- Isolation and use of solid tumor stem cells89US 6,984,522 B2The Regents of the University of Michigan · 2006